Evidence map›Paper›PMID 37582220›Full record

ArticleEnvironmental science & technology2023

Variability of the Human Serum Metabolome over 3 Months in the EXPOsOMICS Personal Exposure Monitoring Study.

Max J Oosterwegel, Dorina Ibi, Lützen Portengen, Nicole Probst-Hensch, Sonia Tarallo, Alessio Naccarati, Medea Imboden, Ayoung Jeong, Nivonirina Robinot, Augustin Scalbert and 8 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in Environmental science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Max J OosterwegelDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.ORCID 0000-0003-3991-2632
Dorina IbiDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.
Lützen PortengenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.
Nicole Probst-HenschSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.
Sonia TaralloItalian Institute for Genomic Medicine (IIGM), c/o IRCCS, Turin 10060, Italy.
Alessio NaccaratiItalian Institute for Genomic Medicine (IIGM), c/o IRCCS, Turin 10060, Italy.ORCID 0000-0001-5774-0905
Medea ImbodenSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.
Ayoung JeongSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.
Nivonirina RobinotNutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon CS 90627, France.
Augustin ScalbertNutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon CS 90627, France.
Andre F S AmaralNational Heart and Lung Institute, Imperial College London, London SW3 6LY, U.K.
Erik van NunenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.ORCID 0000-0001-6079-0030
John GulliverMedical Research Council-Public Health England Center for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0003-3423-2013
Marc Chadeau-HyamDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.ORCID 0000-0001-8341-5436
Paolo VineisMedical Research Council-Public Health England Center for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0001-8935-4566
Roel VermeulenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.
Pekka Keski-RahkonenNutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon CS 90627, France.
Jelle VlaanderenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.

Funding

Medical Research Council MR/S019669/1World Health Organization 001
6 · The paper itself

Abstract

Liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) and untargeted metabolomics are increasingly used in exposome studies to study the interactions between nongenetic factors and the blood metabolome. To reliably and efficiently link detected compounds to exposures and health phenotypes in such studies, it is important to understand the variability in metabolome measures. We assessed the within- and between-subject variability of untargeted LC-HRMS measurements in 298 nonfasting human serum samples collected on two occasions from 157 subjects. Samples were collected ca. 107 (IQR: 34) days apart as part of the multicenter EXPOsOMICS Personal Exposure Monitoring study. In total, 4294 metabolic features were detected, and 184 unique compounds could be identified with high confidence. The median intraclass correlation coefficient (ICC) across all metabolic features was 0.51 (IQR: 0.29) and 0.64 (IQR: 0.25) for the 184 uniquely identified compounds. For this group, the median ICC marginally changed (0.63) when we included common confounders (age, sex, and body mass index) in the regression model. When grouping compounds by compound class, the ICC was largest among glycerophospholipids (median ICC 0.70) and steroids (0.67), and lowest for amino acids (0.61) and the O-acylcarnitine class (0.44). ICCs varied substantially within chemical classes. Our results suggest that the metabolome as measured with untargeted LC-HRMS is fairly stable (ICC > 0.5) over 100 days for more than half of the features monitored in our study, to reflect average levels across this time period. Variance across the metabolome will result in differential measurement error across the metabolome, which needs to be considered in the interpretation of metabolome results.

Indexed as

MetabolomeMetabolomicsChromatography, LiquidHumansMass SpectrometryPhenotypebetween-individual variabilitybiomarkersbloodcohort studyepidemiologyintraclass correlation coefficient (ICC)liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS)metabolomicsreliabilityrepeatabilityvariabilitywithin-individual variability

Identifiers

PMID37582220
PMCPMC10469440

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.